Idt Australia Limited. operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Idt Australia Limited. with three other
companies in this sector in Australia:
Cellmid Limited
(2019
sales of 7.47 million Australian Dollars [US$5.11 million]
),
Benitec Biopharma Limited
(16.60 million Australian Dollars [US$11.36 million]
), and
Pharmaxis Ltd
(12.55 million Australian Dollars [US$8.58 million]
of which 48%
was New Drug Development).
Sales Analysis.
Idt Australia Limited. reported sales of A$12.13 million (US$8.30 million)
for the
fiscal
year ending
June of 2019.
This
represents
a
decrease of 8.8%
versus 2018, when the company's sales were A$13.30 million.
The sales level in 2019 was fairly close to the level five years ago: in 2014, Idt Australia Limited. had sales
of A$13.37 million.